Bilal Arif
Chief Tech/Sci/R&D Officer at SAREPTA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-04-29
Bilal Arif active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-30 | - |
| Corporate Officer/Principal | - | 2022-12-30 |
Career history of Bilal Arif
Former positions of Bilal Arif
| Companies | Position | Start | End |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-12-31 | 2019-01-01 |
Training of Bilal Arif
| Tufts University | Graduate Degree |
| McGill University | Undergraduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Statistics
International
| United States | 4 |
| Canada | 2 |
| Spain | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Bilal Arif
- Experience
